TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL DNA POLYMERASE MARKET,BY TYPE
6.1. Overview
6.2. Taq Polymerase
6.3. Pfu Polymerase
6.4. Proprietary Enzyme Blends
7. GLOBAL DNA POLYMERASE MARKET,BY APPLICATION
7.1. Overview
7.2. Polymerase Chain Reaction
7.3. DNA Sequencing
7.4. DNA Cloning
7.5. SNP Analysis
7.6. Next Generation Sequencing
8. GLOBAL DNA POLYMERASE MARKET,BY END-USER
8.1. Overview
8.2. Biopharmaceutical Companies
8.3. Academic and Research Institutes
8.4. Hospitals and Diagnostic Centers
8.5. Molecular Diagnostic Companies
9. GLOBAL DNA POLYMERASE MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global DNA Polymerase Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global DNA Polymerase Market,
10.7. Key developments and Growth Strategies
10.7.1. New ProductLaunch/Service Deployment
10.7.2. Merger &Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income,2022
10.8.2. Major Players R&D Expenditure.2022
11. COMPANY PROFILES
11.1. Merck KGaA
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Danaher.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Thermo Fisher Scientific, Inc.
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Agilent Technologies.
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. QIAGEN.
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Hoffmann-La Roche Ltd.
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Promega Corporation
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. New England Biolabs
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Bio-Rad Laboratories, Inc..
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Takara Bio, Inc.
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL DNA POLYMERASE MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL DNA POLYMERASE MARKET, ESTIMATES &FORECAST, 2018-2032(USD BILLION)
TABLE 3 GLOBAL DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL DNA POLYMERASE MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL DNA POLYMERASE MARKET,BY END-USER, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: DNA POLYMERASE MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: DNA POLYMERASE MARKET,BY END-USER, 2018-2032 (USD BILLION)
TABLE 9 US: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 10 US: DNA POLYMERASE MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 11 US: DNA POLYMERASE MARKET,BY END-USER, 2018-2032 (USD BILLION)
TABLE 12 CANADA: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 13 CANADA: DNA POLYMERASE MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 14 CANADA: DNA POLYMERASE MARKET,BY END-USER, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: DNA POLYMERASE MARKET, BY APPLICATION , 2018-2032 (USD BILLION)
TABLE 3 EUROPE: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 4 GERMANY: DNA POLYMERASE MARKET,BY TYPE,2018-2032 (USD BILLION)
TABLE 5 GERMANY: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 6 GERMANY: DNA POLYMERASE MARKET, BY END-USER , 2018-2032 (USD BILLION)
TABLE 7 FRANCE: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 8 FRANCE: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 FRANCE: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 10 ITALY: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 11 ITALY: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 12 ITALY: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 13 SPAIN: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 14 SPAIN: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 SPAIN: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 16 UK: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 17 UK: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 18 UK: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 25 JAPAN: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 26 JAPAN: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 27 JAPAN: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 28 CHINA: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 29 CHINA: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 30 CHINA: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 31 INDIA: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 32 INDIA: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 33 INDIA: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 34 AUSTRALIA: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 35 AUSTRALIA: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 36 AUSTRALIA: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 49 AFRICA: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 50 AFRICA: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 51 AFRICA: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: DNA POLYMERASE MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: DNA POLYMERASE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: DNA POLYMERASE MARKET, BY END-USER, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL DNA POLYMERASE MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL DNA POLYMERASE MARKET
FIGURE 4 GLOBAL DNA POLYMERASE MARKET, SHARE (%), BY TYPE, 2022
FIGURE 5 GLOBAL DNA POLYMERASE MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 6 GLOBAL DNA POLYMERASE MARKET, SHARE (%), BY END-USER, 2022
FIGURE 7 GLOBAL DNA POLYMERASE MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: DNA POLYMERASE MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 EUROPE: DNA POLYMERASE MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 ASIA-PACIFIC: DNA POLYMERASE MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 REST OF THE WORLD: DNA POLYMERASE MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 GLOBAL DNA POLYMERASE MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 13 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 MERCK KGAA: SWOT ANALYSIS
FIGURE 15 DANAHER.:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 DANAHER.:SWOT ANALYSIS
FIGURE 17 THERMO FISHER SCIENTIFIC, INC.:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 THERMO FISHER SCIENTIFIC, INC.:SWOT ANALYSIS
FIGURE 19 AGILENT TECHNOLOGIES.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 AGILENT TECHNOLOGIES.:SWOT ANALYSIS
FIGURE 21 QIAGEN:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 QIAGEN:SWOT ANALYSIS
FIGURE 23 HOFFMANN-LA ROCHE LTD.:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 HOFFMANN-LA ROCHE LTD.:SWOT ANALYSIS
FIGURE 25 PROMEGA CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 PROMEGA CORPORATION: SWOT ANALYSIS
FIGURE 27 NEW ENGLAND BIOLABS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 NEW ENGLAND BIOLABS: SWOT ANALYSIS
FIGURE 29 BIO-RAD LABORATORIES, INC..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 BIO-RAD LABORATORIES, INC..: SWOT ANALYSIS
FIGURE 31 TAKARA BIO, INC..:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 TAKARA BIO, INC..:SWOT ANALYSIS
